{"name":"Lipella Pharmaceuticals, Inc.","slug":"lipella-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":536357,"revenueGrowth":19.3,"grossMargin":0,"rdSpend":3613187,"netIncome":-5016264,"cash":2184863,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54YTd6U0Z6bkhSVmR3cEFEd2lESjRaQjRpZU1paTR6T1dmQjVJTFJETkd3UXNSaGdja1NQbDFocDVaZHV0M0NyRThZT2REM1RWYldvMTJQanRiYS00NzEzVTB1Njl1bEpOQ19ST0x6cmUzTlRKZ2pOZDQtNnI?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNc1hGZnROYjRGdHc2dExBWTZaSHREX1l4bmxOQkFEX0U5bGNxVmNhb3RYSHFrMG9xV0dYb19Ga29rVVNzMW1LbnM4UHFzYklNV2cyUHlUOGdQNG9CNDZzMVlMZjhfY1BfQWNWUlNvcmU3dU5uZTQ3eUhxZkNiQklfRjZiN1BOZnJvN09SdlJwNzFYVGlNQXpRdE95c3JySzJZd1djOWxDTDAxY2hwXzhSMmEtbXh1UQ?oc=5","date":"2026-03-31","type":"pipeline","source":"National Today","summary":"Lipella Pharmaceuticals Files for Chapter 11 Bankruptcy - National Today","headline":"Lipella Pharmaceuticals Files for Chapter 11 Bankruptcy","sentiment":"neutral"},{"date":"2026-03-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-10-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-09-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNa1ZCNlJqWm1HMGJma192eUFmYURyWWhPLWwtS19GQS0wSjAwdUlEdXJPclBaMlZNVjgtZkJIdERPNWZSd28zY29BVmtHRHpBSDdvOWt0R0JXZXV3VnZ5cEZjY1A2N1pNU1dLS29ic2ZuV2ItRldhdzhOa3hma0gyczljUlhHd1AwUlhoRG9VMnlSV0kyVW4tZGdMWlNvc2NpWHFGLVFiVUwyZUlKaUxvYWoyMDlnaUpYU0NBemxGNnlrcGtjM2wyeGpTbUMybVE5VEw0VW1kOFVHWkZCUWZINzE3OXlnQ0FzNlRZNFFTeHZIRjZr?oc=5","date":"2025-08-04","type":"trial","source":"PR Newswire","summary":"Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxObzROck1UdWYyLVJ5TjdNX0lOaEpqY0JmaGlxTEhBV1dEbXVMZnJpalgzYzREOEtQdXJSLXljd0JzcWlSZDBrZ1AwM0xwRHpCQ0FNZmkzcUN0RVB4ZGdTdWN5MmduMHE3ZU5qbk5yWXItVmlzeWhCWGtmdzFxWUQxd3BBazlMUDZkM2FMUDZIcDY?oc=5","date":"2025-06-25","type":"pipeline","source":"Yahoo Finance","summary":"Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting - Yahoo Finance","headline":"Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting","sentiment":"neutral"},{"date":"2025-06-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPWG9EV0RCU05KdFVfbHA5RkdnQzBfX25Uc2lObmhSN3R0R19BQTFxVG9TUGpHSDlxbWxhV0RvXzN5WFAyMlo1V2t6dklPVjRwN21sNWlNUGdlWU5zeFY0c2hhSjd4MUpFbFZXanUwajhxZHQ0WHc0MnBJQVFLRzJ2YWphbC05OW1Vdi1uRG9DY19CU3FFajIxZkpGV2J3d2ZMalZKRVFZZFJlUUdHbXd0QWhJU0kwS0hrV3NkZXp4cFNDaDNyeE5SNmt5VWo2LWU2RTdtQnZYcHNwQQ?oc=5","date":"2025-06-20","type":"pipeline","source":"globenewswire.com","summary":"Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market - globenewswire.com","headline":"Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market","sentiment":"neutral"},{"date":"2025-06-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-06-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":536357,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":536357,"period":"2024-12-31"},{"value":449617,"period":"2023-12-31"},{"value":184156,"period":"2022-12-31"},{"value":259347,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":3613187,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5016264,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":2184863,"cashHistory":[],"totalAssets":2673870,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}